GlaxoSmithKline Executive Prevented from Leaving China

China has stepped up its anti-corruption campaign against GlaxoSmithKline, blocking a senior executive of one of the world’s largest pharmaceutical companies from leaving the country...

Preventing a foreign executive from leaving the country is bound to create a stir among Western companies, some analysts said.

“Whether it is going to create a problem for the expatriates who live in China, certainly it will have a negative impact, but I do not think it will be dramatic,” said Siva Yam, president of the United States of America-China Chamber of Commerce.

But he noted: “It does not matter if they are foreign or Chinese, if they have committed a crime based on the local law then they have a problem.”